Revascularization Strategies and Survival in Patients With Multivessel Coronary Artery Disease.


Journal

The Annals of thoracic surgery
ISSN: 1552-6259
Titre abrégé: Ann Thorac Surg
Pays: Netherlands
ID NLM: 15030100R

Informations de publication

Date de publication:
01 2019
Historique:
received: 16 01 2018
revised: 23 05 2018
accepted: 23 07 2018
pubmed: 30 9 2018
medline: 11 10 2019
entrez: 30 9 2018
Statut: ppublish

Résumé

We sought to assess real-world implementation of the guidelines in patients with multivessel coronary artery disease (CAD) using a prospective national registry in Israel. All consecutive patients with left main or 2- to 3-vessel CAD involving the proximal or mid left anterior descending artery were enrolled in a dedicated multicenter registry. Patients were managed at the discretion of the treating team at each hospital and were followed for 30 months. This registry included 1,064 patients, 55% treated with percutaneous coronary intervention (PCI) and 45% with coronary artery bypass surgery (CABG). Multivariate logistic regression analysis showed that chronic renal failure (odds ratio [OR], 2.43; p = 0.001) and prior myocardial infarction (OR, 1.7; p = 0.024) were associated with referral to PCI versus CABG, whereas male gender (OR, 2.27; p < 0.001), prior aspirin treatment (OR, 1.72; p = 0.005), diabetes mellitus (OR, 1.51; p = 0.007), 3-vessel CAD (OR, 3.45; p < 0.001) and SYNTAX score (SS) greater than 32 (OR, 10.0; p < 0.001) were associated with referral to CABG versus PCI. Each point increment in the SS was independently associated with a 9% greater likelihood of referral to CABG (p < 0.001). Survival analysis showed that mortality risk was lower among PCI patients less than 8 months after the procedure, and CABG was associated with a significant survival benefit thereafter. We found good agreement with current guidelines regarding revascularization strategies in real-world patients with multivessel CAD. The SS was the main independent predictor associated with the choice of revascularization strategy. The time-dependent association between revascularization strategy and long-term survival should be incorporated in the risk assessment of this population.

Sections du résumé

BACKGROUND
We sought to assess real-world implementation of the guidelines in patients with multivessel coronary artery disease (CAD) using a prospective national registry in Israel.
METHODS
All consecutive patients with left main or 2- to 3-vessel CAD involving the proximal or mid left anterior descending artery were enrolled in a dedicated multicenter registry. Patients were managed at the discretion of the treating team at each hospital and were followed for 30 months.
RESULTS
This registry included 1,064 patients, 55% treated with percutaneous coronary intervention (PCI) and 45% with coronary artery bypass surgery (CABG). Multivariate logistic regression analysis showed that chronic renal failure (odds ratio [OR], 2.43; p = 0.001) and prior myocardial infarction (OR, 1.7; p = 0.024) were associated with referral to PCI versus CABG, whereas male gender (OR, 2.27; p < 0.001), prior aspirin treatment (OR, 1.72; p = 0.005), diabetes mellitus (OR, 1.51; p = 0.007), 3-vessel CAD (OR, 3.45; p < 0.001) and SYNTAX score (SS) greater than 32 (OR, 10.0; p < 0.001) were associated with referral to CABG versus PCI. Each point increment in the SS was independently associated with a 9% greater likelihood of referral to CABG (p < 0.001). Survival analysis showed that mortality risk was lower among PCI patients less than 8 months after the procedure, and CABG was associated with a significant survival benefit thereafter.
CONCLUSIONS
We found good agreement with current guidelines regarding revascularization strategies in real-world patients with multivessel CAD. The SS was the main independent predictor associated with the choice of revascularization strategy. The time-dependent association between revascularization strategy and long-term survival should be incorporated in the risk assessment of this population.

Identifiants

pubmed: 30267693
pii: S0003-4975(18)31322-5
doi: 10.1016/j.athoracsur.2018.07.070
pii:
doi:

Types de publication

Comparative Study Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

106-111

Informations de copyright

Copyright © 2019 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Auteurs

Noam Fink (N)

Leviev Heart Center, Chaim Sheba Medical Center, Tel Hashomer, Israel. Electronic address: noamfink@bezeqint.net.

Eugenia Nikolsky (E)

Division of Cardiology, Rambam Healthcare Center, Haifa, Israel.

Abid Assali (A)

Division of Cardiology, Rabin Medical Center, Petach-Tikva, Israel.

Oz Shapira (O)

Department of Cardiac Surgery, Hadassah Medical Center, Jerusalem, Israel.

Yigal Kassif (Y)

Leviev Heart Center, Chaim Sheba Medical Center, Tel Hashomer, Israel.

Yaron D Barac (YD)

Department of Cardiac Surgery, Rabin Medical Center, Petach-Tikva, Israel.

Ariel Finkelstein (A)

Division of Cardiology, Tel Aviv Medical Center, Tel Aviv, Israel.

Amnon Eitan (A)

Division of Cardiology, Rambam Healthcare Center, Haifa, Israel.

Haim Danenberg (H)

Division of Cardiology, Hadassah Medical Center, Jerusalem, Israel.

Doron Zahger (D)

Division of Cardiology, Soroka Medical Center, Beer-Sheva, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Gideon Sahar (G)

Department of Cardiac Surgery, Soroka Medical Center, Beer-Sheva, Israel.

Shaul Atar (S)

Division of Cardiology, Galilee Medical Center, Naharyiah, Faculty of Medicine in the Galilee, Bar Ilan University, Ramat Gan, Israel.

Ehud Raanani (E)

Leviev Heart Center, Chaim Sheba Medical Center, Tel Hashomer, Israel.

Gil Bolotin (G)

Department of Cardiovascular Surgery, Rambam Healthcare Center, Haifa, Israel.

Ilan Goldenberg (I)

Leviev Heart Center, Chaim Sheba Medical Center, Tel Hashomer, Israel.

Amit Segev (A)

Leviev Heart Center, Chaim Sheba Medical Center, Tel Hashomer, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH